FDA to review Lilly Tirz shortage decision.

Pretty interesting. I'm surprised they're willing to reexamine it, I guess they really didn't think there would be this much pushback. The decision was clearly nonsense to begin with but I don't think I need to tell anyone here that.

That decision is what brought me here from LSH, but I'm not planning on going back to compound unless prices go wayyyyy down. I'm very grateful those places exist for less technical people but gray market's just so much cheaper.
 
New update from the LSH Facebook page:

"Hallandale just informed us they will be providing Tirzepatide again pending FDA re-evaluation of the shortage. This may change at any time, and we will keep you informed as we are informed."

So, their go-to lab is back in the Tirz game again. Things should quiet down here now. lol
 
Back
Top